Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
PA

NASDAQ · PAVM

PAVmed Inc.

Healthcare · Medical - Devices

$2.69

Up+$0.10 (+3.72%)

Updated Oct 9, 2026, 11:25 PM

SID Score

3.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
6.07M
P/E ratio
-0
Dividend yield
0.00%
52-week range
$2.60 – $10.80
Volume
4.14K
Avg. volume
505.07K

Price performance · PAVM

PAVM price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 8, 2026

PAVM closed at $2.69 after 21 trading sessions, down 37.00% for the selected period.

Last close
$2.69
Period change
-37.00%
Period low
$2.66
Period high
$4.39
Daily close
View OHLC price history
PAVM OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 8, 2026$2.76$2.76$2.655$2.694.14K
Oct 7, 2026$2.6977$2.84$2.60$2.7428.14K
Oct 6, 2026$2.65$2.93$2.65$2.67515.25K
Oct 5, 2026$2.81$2.845$2.66$2.667.39K
Oct 2, 2026$2.69$2.99$2.65$2.8728.6K
Oct 1, 2026$3.6112$3.69$2.61$2.70187.96K
Sep 30, 2026$3.70$3.785$3.66$3.693.25K
Sep 29, 2026$3.83$4.07$3.815$3.8154.97K
Sep 28, 2026$3.78$4.13$3.78$3.7958.55K
Sep 25, 2026$3.89$4.06$3.75$3.84524.3K
Sep 24, 2026$4.15$4.30$3.85$3.889.99K
Sep 23, 2026$4.07$4.14$3.9875$3.98752.71K
Sep 22, 2026$3.90$4.33$3.86$4.182516.96K
Sep 21, 2026$3.91$4.01$3.79$3.9733.1K
Sep 18, 2026$3.97$4.29$3.88$3.9623.31K
Sep 17, 2026$4.02$4.06$3.90$3.978.79K
Sep 16, 2026$4.05$4.2233$3.92$3.9247.91K
Sep 15, 2026$4.26$4.36$3.70$3.9230.68K
Sep 14, 2026$4.45$4.62$4.11$4.3960.84K
Sep 11, 2026$4.22$4.305$4.14$4.187.91K
Sep 10, 2026$4.44$4.62$4.11$4.2723.92K

Latest PAVM news

The latest Smart Investors Daily articles mentioning PAVM.

Stock researchCompany · Overview

PAVM research

Overview

Company profile and research snapshot.

Company profile

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
PAVM recent ratings
DateFirmRatingTarget
Aug 27, 2026Ascendiant CapitalBuy—
Jun 8, 2026Ascendiant CapitalBuy—
Apr 9, 2026Ascendiant CapitalBuy—
Dec 10, 2025Ascendiant CapitalBuy—
Oct 6, 2025Ascendiant CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 22, 2026

Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced advances in multiple payment, billing, and coding pathways for its EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device, following three public meetings held last week.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By